Lactate Control Enhances Growth Advantage in Fed-batch Cultures
of Metabolically Engineered CHO Cells with Reduced Novel
Growth-inhibitory Compound Formation
Quentin Bethune1, Cameron
Harrington1 and Bhanu Chandra
Mulukutla2
Upstream Process Development, Pfizer Inc, One Burtt Road, Andover MA,
01810, USA
1 Contributed equally
2 Corresponding author (email:
bhanuchandra.mulukutla@pfizer.com)